---
url: 'https://qubit.capital/blog/europe-series-a-weekly-funding-roundup-week-5-march-2026'
title: 'Europe Series A Weekly Funding Roundup (Mar 23-30, 2026): $38.0M Raised Across 2 Deals'
author:
  name: Vaibhav Totuka
  url: 'https://qubit.capital/blog/author/vaibhav-totuka'
date: '2026-03-30T04:14:20+05:30'
modified: '2026-03-30T11:26:31+05:30'
type: post
summary: Two Paris-based startups raised $38M in Series A funding this week. Parallel secured $20M for AI hospital agents and Escape raised $18M for offensive cybersecurity.
categories:
  - Weekly Funding Roundup
image: 'https://qubit.capital/wp-content/uploads/2026/03/featured-europe-series-a-64871.webp'
published: true
---

# Europe Series A Weekly Funding Roundup (Mar 23-30, 2026): $38.0M Raised Across 2 Deals

Two Paris-based startups closed Series A rounds this week, raising a combined $38 million. Both companies are building AI agent systems, but for very different markets: one automates hospital paperwork, the other hacks your software before criminals do.

The common thread is clear. European investors are backing companies that deploy AI agents into high-friction, regulated environments where automation has historically been blocked by compliance barriers and legacy infrastructure. Index Ventures and Balderton Capital each led one of these rounds, signaling confidence in vertical AI plays that tackle specific operational pain points rather than broad horizontal platforms.

Weekly Funding Roundup
MAR 23-30, 2026

$38M
TOTAL RAISED

2DEALS CLOSED
100%SERIES A
$19MAVG DEAL SIZE
EUROPETOP REGION

BY STAGE
Series A$38M100%

BY SECTOR
ParallelHealthtech$20M
EscapeCybersecurity$18M

        
            
            
                
                    
                        
                            
                                
                                    Table of Contents                                
                                
                                                                    
                            
                            
                                
                                        

      - 
        [1. Parallel Raises $20M For AI Hospital Agents](#1-parallel-raises-$20m-for-ai-hospital-agents)
        

          
            [Deal Overview](#deal-overview)
          

          - 
            [Investor Profile](#investor-profile)
          

          - 
            [Company and Leadership](#company-and-leadership)
          

          - 
            [Problem and Opportunity](#problem-and-opportunity)
          

          - 
            [Product and Technology](#product-and-technology)
          

          - 
            [Use of Proceeds and Vision](#use-of-proceeds-and-vision)
          

          - 
            [Market Context](#market-context)
          

        

      
      - 
        [2. Escape Raises $18M For AI-Powered Offensive Security](#2-escape-raises-$18m-for-ai-powered-offensive-security)
        

          
            [Deal Overview](#deal-overview-1)
          

          - 
            [Investor Profile](#investor-profile-1)
          

          - 
            [Company and Leadership](#company-and-leadership-1)
          

          - 
            [Problem and Opportunity](#problem-and-opportunity-1)
          

          - 
            [Product and Technology](#product-and-technology-1)
          

          - 
            [Use of Proceeds and Vision](#use-of-proceeds-and-vision-1)
          

          - 
            [Market Context](#market-context-1)
          

        

      
      - 
        [Lessons For Founders](#lessons-for-founders)
      

    

                                
                            
                        
                    
                    
                        
                    
                
            

    
## 1. Parallel Raises $20M For AI Hospital Agents

### Deal Overview

- **Stage:** Series A

- **Sector:** Healthtech

- **Geography:** Paris, France

- **Round Size:** $20M

- **Lead Investor:** Index Ventures

### Investor Profile

Index Ventures led the round, joined by Frst (which also led the seed), Y Combinator, and Hexa. The angel list is notable: Arthur Mensch of Mistral AI, Vincent Bouvier of Vidal, and the co-founders of Pennylane all participated. When the founder of France’s most prominent AI company backs your healthtech startup, it says something about the technical credibility of the team.

### Company and Leadership

[Parallel](https://www.beparallel.com) was co-founded by Paul Lafforgue and Christopher Rydahl. Lafforgue, the CEO, spent time at Meta and McKinsey after graduating from École polytechnique and HEC. Rydahl brings direct healthcare operating experience as the co-founder of Hublo, Europe’s largest healthcare staffing platform, which raised €22M and served over 2,800 facilities. The company went from a $3.5M seed in April 2025 to this Series A in under a year.

### Problem and Opportunity

Roughly 30% of healthcare spending goes to administration. In the US alone, that’s close to $1 trillion a year. Hospital staff spend hours converting clinical records into standardized reimbursement codes, a tedious process that pulls them away from patient care. The problem isn’t that hospitals don’t want software. It’s that integrating new systems into legacy hospital IT typically takes 12 to 24 months, which kills most automation projects before they start.

### Product and Technology

Parallel built a Medical Coding Agent that uses LLMs and computer-use agents to sit on top of existing hospital systems. Instead of requiring deep integrations, the AI connects via remote VPN and robotic process automation. It reads screens and enters data the way a human would. Deployment takes about one week. All data stays in EU-hosted infrastructure with RGPD, HDS, and ISO 27001 compliance, and the company doesn’t train models on hospital data. Several dozen public and private hospitals already use the system.

### Use of Proceeds and Vision

The $20M will fund rollout of the medical coding agent to more hospitals, international expansion beyond Europe, and development of new agents for billing, admissions, and insurance verification. The long-term goal is to automate the administrative burden that keeps medical staff buried in paperwork instead of treating patients.

### Market Context

Hospital AI automation is still early. Aging populations are increasing demand while regulatory complexity multiplies the administrative load. Staffing shortages make the math worse every year. Parallel faces minimal direct competition in its specific approach of UI-automation-based hospital agents, which sidesteps the integration problem that has stalled previous attempts at healthcare automation.

## 2. Escape Raises $18M For AI-Powered Offensive Security

### Deal Overview

- **Stage:** Series A

- **Sector:** Cybersecurity

- **Geography:** Paris, France

- **Round Size:** $18M

- **Lead Investor:** Balderton Capital

### Investor Profile

Balderton Capital led alongside Uncorrelated Ventures, with Y Combinator and IRIS (which led the seed) also participating. Balderton has a strong track record in European cybersecurity, and Uncorrelated Ventures’ involvement brings deep US enterprise security distribution knowledge. Total funding now stands at $23M.

### Company and Leadership

[Escape](https://www.escape.tech) was co-founded by Tristan Kalos (CEO) and Antoine Carossio (CTO), both named to Forbes 30 Under 30. Carossio previously worked as a security engineer for the French Government and Apple. The company came through Y Combinator’s W23 batch and has grown to serve over 2,000 security teams globally. One customer reported 393% ROI after cutting testing time from five days to five hours.

### Problem and Opportunity

Security teams are outnumbered by developers roughly 100 to 1. Annual penetration tests and fragmented scanning tools can’t keep pace with modern development velocity. When teams ship code multiple times a day, a pentest that happens once a year leaves massive gaps. The rise of AI-powered attacks makes this asymmetry even more dangerous.

### Product and Technology

Escape offers three core products: Attack Surface Management for continuous visibility across code and cloud, Business-Logic-Aware DAST that replaces legacy scanners with context-aware testing, and AI Pentesting that delivers senior pentester depth at continuous scale. The platform uses agentic attack reasoning powered by graph context to find multi-step attack chains, including IDOR vulnerabilities and multi-tenant security gaps. It runs continuously rather than on a schedule.

### Use of Proceeds and Vision

Funds will expand the platform’s AI agent capabilities, grow the engineering team with a focus on agentic pentesting R&D, and scale go-to-market efforts across the US and Europe. The company wants to replace legacy scanners and manual offensive security processes entirely with AI agents that automate discovery, testing, and remediation.

### Market Context

Enterprise demand for continuous vulnerability discovery is growing fast alongside DevSecOps adoption. The shift from annual pentest cycles to always-on security testing creates a large market opportunity. Escape’s crowdsourced adversarial data from thousands of continuous pentests compounds over time, giving them a data advantage that gets harder for competitors to match with each new deployment.

## Lessons For Founders

- **Skip the integration, ship faster.** Parallel’s one-week deployment via UI automation versus 12-24 month traditional integrations shows that the fastest path to adoption in regulated industries is often working on top of existing systems rather than replacing them.

- **Founder-market fit accelerates everything.** Both companies have founders with deep domain experience. Rydahl’s healthcare staffing background at Hublo and Carossio’s government security work gave them insider knowledge that shaped product decisions from day one.

- **YC alumni keep raising.** Both Parallel and Escape came through Y Combinator. The network effect of YC’s brand with European investors is real, particularly when paired with strong European-focused leads like Index and Balderton.

- **Compliance as a feature, not a barrier.** Parallel’s healthcare certifications and Escape’s production-infrastructure access both required significant upfront investment in trust and compliance. That investment now functions as a competitive moat.

- **Continuous beats periodic.** Escape’s always-on pentesting and Parallel’s persistent hospital agents both reflect a broader market shift from point-in-time services to continuous AI-powered operations. Founders building for regulated markets should design for sustained deployment from the start.

